PDS Biotechnology (PDSB) Preferred Dividend Payments (2014 - 2015)
PDS Biotechnology's (PDSB) quarterly Preferred Dividend Payments came in at $99325.0 in Q4 2015, down 80.08% YoY from $498594.0 in Q4 2014, and down 94.57% on a QoQ basis from $1.8 million in Q3 2015.
PDS Biotechnology (PDSB) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
PDS Biotechnology (PDSB) has 2 years of Preferred Dividend Payments data on file, last reported at $99325.0 in Q4 2015.
- Quarterly Preferred Dividend Payments fell 80.08% year-over-year to $99325.0 in Q4 2015, while the trailing twelve-month figure through Sep 2016 was $99325.0 (down 97.91% YoY) and the FY2015 annual result came in at $4.4 million, up 175.6% from the prior year.
- Preferred Dividend Payments eased to $99325.0 in Q4 2015, from $1.8 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.8 million in Q3 2015 to a low of $99325.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 99,325.00 |
| Sep 30, 2015 | 1.83 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Mar 31, 2015 | 683,181.00 |
| Dec 31, 2014 | 498,594.00 |
| Sep 30, 2014 | 364,666.00 |